Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization N Nakamoto, DE Kaplan, J Coleclough, Y Li, ME Valiga, M Kaminski, ... Gastroenterology 134 (7), 1927-1937. e2, 2008 | 306 | 2008 |
Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C DE Kaplan, K Sugimoto, K Newton, ME Valiga, F Ikeda, A Aytaman, ... Gastroenterology 132 (2), 654-666, 2007 | 205 | 2007 |
Reciprocal actions of interleukin‐6 and brain‐derived neurotrophic factor on rat and mouse primary sensory neurons PG Murphy, LA Borthwick, M Altares, J Gauldie, D Kaplan, PM Richardson European Journal of Neuroscience 12 (6), 1891-1899, 2000 | 112 | 2000 |
Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans DS Goldberg, B French, KA Forde, PW Groeneveld, T Bittermann, ... Jama 311 (12), 1234-1243, 2014 | 99 | 2014 |
Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality M Serper, TH Taddei, R Mehta, K D’Addeo, F Dai, A Aytaman, ... Gastroenterology 152 (8), 1954-1964, 2017 | 87 | 2017 |
Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores GN Ioannou, LA Beste, PK Green, AG Singal, EB Tapper, AK Waljee, ... Gastroenterology 157 (5), 1264-1278. e4, 2019 | 85 | 2019 |
Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis DE Kaplan, F Ikeda, Y Li, N Nakamoto, S Ganesan, ME Valiga, FA Nunes, ... Journal of hepatology 48 (6), 903-913, 2008 | 84 | 2008 |
Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study V Lo Re III, V Teal, AR Localio, VK Amorosa, DE Kaplan, R Gross Annals of internal medicine 155 (6), 353-360, 2011 | 83 | 2011 |
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular‐cholangiocarcinoma X Cai, J Zhai, DE Kaplan, Y Zhang, L Zhou, X Chen, G Qian, Q Zhao, Y Li, ... Hepatology 56 (5), 1804-1816, 2012 | 76 | 2012 |
Dysfunctional B‐cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27‐Positive B‐cell population H Doi, TK Iyer, E Carpenter, H Li, KM Chang, RH Vonderheide, ... Hepatology 55 (3), 709-719, 2012 | 74 | 2012 |
Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes T Kushner, M Serper, DE Kaplan Journal of hepatology 63 (3), 586-592, 2015 | 64 | 2015 |
Focal distribution of hepatitis C virus RNA in infected livers JD Stiffler, M Nguyen, JA Sohn, C Liu, D Kaplan, C Seeger PLoS One 4 (8), e6661, 2009 | 64 | 2009 |
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis DS Goldberg, TH Taddei, M Serper, R Mehta, E Dieperink, A Aytaman, ... Hepatology 65 (3), 864-874, 2017 | 62 | 2017 |
Relative performance of commercial banks in India using CAMEL approach KS Reddy International Journal of Multidisciplinary Research 2 (3), 38-58, 2012 | 62 | 2012 |
Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database DE Kaplan, F Dai, A Aytaman, M Baytarian, R Fox, K Hunt, A Knott, ... Clinical Gastroenterology and Hepatology 13 (13), 2333-2341. e6, 2015 | 61 | 2015 |
T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C DE Kaplan, K Sugimoto, F Ikeda, J Stadanlick, M Valiga, K Shetty, ... Hepatology 41 (6), 1365-1375, 2005 | 61 | 2005 |
Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans RA Harris, K Sugimoto, DE Kaplan, F Ikeda, M Kamoun, KM Chang Hepatology 48 (1), 70-79, 2008 | 59 | 2008 |
Rare birds in North America: acute hepatitis C cohorts AL Cox, K Page, J Bruneau, NH Shoukry, GM Lauer, AY Kim, HR Rosen, ... Gastroenterology 136 (1), 26, 2009 | 58 | 2009 |
Starting dose of sorafenib for the treatment of hepatocellular carcinoma: a retrospective, multi-institutional study KA Reiss, S Yu, R Mamtani, R Mehta, K D’Addeo, EP Wileyto, TH Taddei, ... Journal of Clinical Oncology 35 (31), 3575, 2017 | 56 | 2017 |
Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection K Sugimoto, DE Kaplan, F Ikeda, J Ding, J Schwartz, FA Nunes, HJ Alter, ... Journal of virology 79 (11), 6976-6983, 2005 | 55 | 2005 |